FREE Case Review (866) 588-0600

Onglyza Lawsuit Filed in New Jersey

A New Jersey man who claims he suffered catastrophic heart damage after taking the diabetes medication Onglyza has filed a lawsuit against the manufacturers.

A New Jersey man has filed a products liability lawsuit against Bristol-Myers Squibb and Astrazeneca Pharmaceuticals, alleging that he suffered life-threatening heart injuries after taking the type 2 diabetes medication saxagliptin, sold under the brand names Onglyza and Kombiglyze XR.

Free Confidential Lawsuit Evaluation: If you or a loved one has been injured by Onglyza side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

What’s the Problem?

July 24, 2017 – According to the lawsuit, Plaintiff Earl Binns claims that he developed coronary artery disease (CAD) and congestive heart failure (CHF) as a result of taking saxagliptin. Binns further alleges that the manufacturers had known for years saxagliptin could increase the risk of life-threatening heart damage.

“Despite such knowledge, defendants knowingly, purposely and deliberately failed to adequately warn plaintiff, patients, consumers, medical providers and the public of the increased risk of serious injury associated with using Saxagliptin including but not limited to heart failure, congestive heart failure, cardiac failure, and death related to those events,” the complaint states.

Plaintiff similarly alleges that the defendants failed to conduct adequate safety testing on saxagliptin or provide sufficient training to sales representatives who sold the medications.

Saxagliptin is used to help lower blood sugar levels in patients with type 2 diabetes. The FDA approved Onglyza in July 2009, and Kombiglyze XR in November 2010.

FDA in April 2016 announced that all type 2 diabetes drugs containing saxagliptin and alogliptin (another similar medication) would have their labels updated to include a heart failure warning.

“Type 2 diabetes medicines containing saxagliptin and alogliptin may increase the risk of heart failure, particularly in patients who already have heart or kidney disease,” the agency said. “Heart failure can result in the heart not being able to pump enough blood to meet the body’s needs.”

The lawsuit is: Earl Binns v. Bristol-Myers Squibb Company et al, Case No. 3:17-cv-03028, US District Court, District of New Jersey.

Do I Have an Onglyza Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Onglyza lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.

Free Case Evaluation: Again, if you were harmed by the side effects of a diabetes medication, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
Awards & recognition